These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. Varier RA; Carrillo de Santa Pau E; van der Groep P; Lindeboom RG; Matarese F; Mensinga A; Smits AH; Edupuganti RR; Baltissen MP; Jansen PW; Ter Hoeve N; van Weely DR; Poser I; van Diest PJ; Stunnenberg HG; Vermeulen M J Biol Chem; 2016 Apr; 291(14):7313-24. PubMed ID: 26841866 [TBL] [Abstract][Full Text] [Related]
27. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Muscat GE; Burke LJ; Downes M Nucleic Acids Res; 1998 Jun; 26(12):2899-907. PubMed ID: 9611234 [TBL] [Abstract][Full Text] [Related]
28. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. Clem BF; Clark BJ Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738 [TBL] [Abstract][Full Text] [Related]
29. The mammalian Sin3 proteins are required for muscle development and sarcomere specification. van Oevelen C; Bowman C; Pellegrino J; Asp P; Cheng J; Parisi F; Micsinai M; Kluger Y; Chu A; Blais A; David G; Dynlacht BD Mol Cell Biol; 2010 Dec; 30(24):5686-97. PubMed ID: 20956564 [TBL] [Abstract][Full Text] [Related]
30. A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II progression within transcribed loci. Jelinic P; Pellegrino J; David G Mol Cell Biol; 2011 Jan; 31(1):54-62. PubMed ID: 21041482 [TBL] [Abstract][Full Text] [Related]
31. EMI1 switches from being a substrate to an inhibitor of APC/C Cappell SD; Mark KG; Garbett D; Pack LR; Rape M; Meyer T Nature; 2018 Jun; 558(7709):313-317. PubMed ID: 29875408 [TBL] [Abstract][Full Text] [Related]
32. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Engeland K Cell Death Differ; 2018 Jan; 25(1):114-132. PubMed ID: 29125603 [TBL] [Abstract][Full Text] [Related]
34. Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression. Boekhout M; Yuan R; Wondergem AP; Segeren HA; van Liere EA; Awol N; Jansen I; Wolthuis RM; de Bruin A; Westendorp B EMBO Rep; 2016 Mar; 17(3):414-27. PubMed ID: 26882548 [TBL] [Abstract][Full Text] [Related]
35. Sin3B mediates collagen type I gene repression by interferon gamma in vascular smooth muscle cells. Weng X; Cheng X; Wu X; Xu H; Fang M; Xu Y Biochem Biophys Res Commun; 2014 May; 447(2):263-70. PubMed ID: 24709079 [TBL] [Abstract][Full Text] [Related]
36. Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Liao M; Zhang Y; Dufau ML Mol Endocrinol; 2008 Jun; 22(6):1449-63. PubMed ID: 18372343 [TBL] [Abstract][Full Text] [Related]
37. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression. Li J; Lin Q; Wang W; Wade P; Wong J Genes Dev; 2002 Mar; 16(6):687-92. PubMed ID: 11914274 [TBL] [Abstract][Full Text] [Related]
38. The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis. Boichuk S; Parry JA; Makielski KR; Litovchick L; Baron JL; Zewe JP; Wozniak A; Mehalek KR; Korzeniewski N; Seneviratne DS; Schöffski P; Debiec-Rychter M; DeCaprio JA; Duensing A Cancer Res; 2013 Aug; 73(16):5120-9. PubMed ID: 23786773 [TBL] [Abstract][Full Text] [Related]
39. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Dhordain P; Lin RJ; Quief S; Lantoine D; Kerckaert JP; Evans RM; Albagli O Nucleic Acids Res; 1998 Oct; 26(20):4645-51. PubMed ID: 9753732 [TBL] [Abstract][Full Text] [Related]
40. SIN3A and SIN3B differentially regulate breast cancer metastasis. Lewis MJ; Liu J; Libby EF; Lee M; Crawford NP; Hurst DR Oncotarget; 2016 Nov; 7(48):78713-78725. PubMed ID: 27780928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]